Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, January 2000, p. 119-121, Vol. 7, No. 1
Department of Internal Medicine I, Intensive
Care Unit 13i2,1 and Division of
Infectious Diseases,2 University of Vienna,
A-1090 Vienna, Austria
Received 1 February 1999/Returned for modification 18 May
1999/Accepted 20 September 1999
The aim of this study was to measure plasma homocysteine and
laminin concentrations in patients with nonbacteremic systemic inflammatory response syndrome (SIRS) and to compare them with those of
a healthy control group. Concerning laminin, significant increased
concentrations could be observed in the SIRS group compared to the
control group, but for homocysteine, no significance could be observed.
In summary, homocysteine and laminin levels are not useful in the
prediction of a patient's outcome.
1071-412X/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Homocysteine and Laminin Are Not Prognostic Markers
in Patients with Septic Inflammatory Response Syndrome
*
Corresponding author. Mailing address: Internal
Medicine I, Division of Infectious Diseases, Währinger
Gürtel 18-20, A-1090 Vienna, Austria. Phone: 43 1 40400 4440. Fax: 43 1 40400 4418. E-mail:
Heinz.Burgmann{at}AKH-Wien.ac.at.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |